Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

PET imaging of neuropathology in tauopathies: progressive supranuclear palsy.

Kepe V, Bordelon Y, Boxer A, Huang SC, Liu J, Thiede FC, Mazziotta JC, Mendez MF, Donoghue N, Small GW, Barrio JR.

J Alzheimers Dis. 2013;36(1):145-53. doi: 10.3233/JAD-130032.

2.

Neuropathology of variants of progressive supranuclear palsy.

Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA.

Curr Opin Neurol. 2010 Aug;23(4):394-400. doi: 10.1097/WCO.0b013e32833be924. Review.

PMID:
20610990
3.

Imaging biomarkers in tauopathies.

Dani M, Edison P, Brooks DJ.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S26-8. doi: 10.1016/j.parkreldis.2015.08.011. Epub 2015 Aug 14. Review.

PMID:
26299160
4.
5.

Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.

Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.

Acta Neurol Scand. 2013 May;127(5):362-70. doi: 10.1111/ane.12067. Epub 2013 Feb 13. Review.

PMID:
23406296
6.

A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Niccolini F, Politis M.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2244-2254. Epub 2016 Jul 28. Review.

7.

Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand?

Stezin A, Lenka A, Jhunjhunwala K, Saini J, Pal PK.

Parkinsonism Relat Disord. 2017 Mar;36:19-32. doi: 10.1016/j.parkreldis.2016.12.023. Epub 2016 Dec 26. Review.

PMID:
28057431
8.

Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2017 May 13. doi: 10.1002/mds.27038. [Epub ahead of print] Review.

PMID:
28500751
9.

Tau PET imaging: present and future directions.

Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A.

Mol Neurodegener. 2017 Feb 20;12(1):19. doi: 10.1186/s13024-017-0162-3. Review.

Supplemental Content

Support Center